Skip to main content
. 1998 Apr 18;316(7139):1200–1205. doi: 10.1136/bmj.316.7139.1200

Table 1.

Selected baseline characteristics of patients with visceral leishmaniasis by treatment. Values are means (SD) unless stated otherwise

Aminosidine
Sodium stibogluconate 20 mg/kg/day (n=30) Comparison (P value)*
12 mg/kg/day (n=30) 16 mg/kg/day (n=30) 20 mg/kg/day (n=30)
Male:female ratio 18:12 18:12 23:7 24:6 0.19
Age (years) 29.83 (14.77) 23.73 (12.02) 29.10 (14.67) 26.07 (12.58) 0.28
Weight (kg) 37.85 (12.80) 35.87 (11.39) 37.63 (12.53) 37.25 (12.44) 0.60
Duration of illness (No of days with fever) 73.57 (57.07) 69.73 (49.28) 90.47 (59.20) 62.33 (40.50) 0.2 
Spleen size (cm) 5.96 (3.59) 6.44 (3.70) 6.36 (4.70) 5.55 (3.45) 0.80
Haemoglobin concentration (g/l)   86 (14.2)    76 (20.1) 82.5 (10.3)  89.2 (13.1)   0.0064
White cell count (109/l) 4.05 (1.16) 3.59 (0.89) 4.04 (1.07) 4.15 (1.13) 0.19
Platelet count (109/l) 210 (66) 178 (34)  168 (56) 178 (50)   0.016
Albumin concentration (g/l) 30.7 (5.0)  30.7 (3.8)  29.9 (4.0) 33.2 (5.2)  0.015
Parasite burden (grade) 2.20 (0.96) 2.03 (0.96) 2.40 (0.81) 1.93 (0.74) 0.18
*

Calculated from one way analysis of variance, except for male:female ratio calculated from χ2 test.  

Significant on Tukey’s honest significance difference.